Chardan Capital Markets
http://www.chardancm.comChardan Capital Markets is an international investment bank headquartered in New York City, with offices in Los Angeles and Beijing. Chardan provides a wide array of financial services including investment banking, capital markets, international trading and equity research. The investment banking group focuses on providing banking and advisory services to private and public companies in small and mid-cap markets. The institutional coverage of Chardan Capital Markets spans North America, Europe and Asia. Chardan Capital Markets LLC is a registered broker-dealer with the U.S. Securities and Exchange Commission and is a member of the following: Financial Industry Regulatory Authority (FINRA); Municipal Securities Rulemaking Board (MSRB); Securities Insurance Protection Corporation (SIPC); NASDAQ Stock Market and the NYSE Arca, Inc.
View Older Stories View More Recent Stories
-
AgeX Therapeutics Reports First Quarter 2021 Financial Results and Provides Business Update
-
Former Penny Stocks To Watch Making Their Mark In 2021
-
Form SC 13G Chardan Healthcare Acqui Filed by: CITADEL ADVISORS LLC
-
Best Penny Stocks To Buy Right Now? 3 For Your May 2021 Watch List
-
Chardan Acts as Exclusive Placement Agent in Forge Biologics' $120 Million Series B Financing
-
Chardan Capital Markets Downgrades Adverum Biotechnologies (ADVM) to Neutral
-
Forge Biologics Announces Closing of $120 Million Series B Financing
-
NeuBase Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
UPDATE: Chardan Capital Starts Achilles Therapeutics (ACHL) at Buy
-
Forge Biologics to Present at Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
-
NeuBase Therapeutics (NBSE) Prices $40 Million Public Offering of Common Stock at $5/sh
-
NeuBase Therapeutics Announces Pricing of $40 Million Public Offering of Common Stock
-
NeuBase Therapeutics (NBSE) Announces Proposed Public Offering of Common Stock
-
Freeline to Participate in Upcoming Investor Conferences in April and May 2021
-
NeuBase Therapeutics Announces Proposed Public Offering of Common Stock
-
Freeline to Participate in Upcoming Investor Conferences in April and May 2021
-
Mustang Bio to Participate in Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
-
Mustang Bio to Participate in Chardan’s 5th Annual Genetic Medicines Manufacturing Summit
-
REGENXBIO To Present at the Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
Solid Biosciences to Participate in Virtual Fireside Chat at the Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
MeiraGTx to Present at Chardan 5th Annual Genetic Medicines Manufacturing Summit
-
Emergent BioSolutions (EBS) Sinks as FDA Requests Pause of Further Production of J&J's (JNJ) COVID-19 Vaccine
-
4D Pharma PLC (LBPS) Named Top Pick at Chardan Capital Markets
-
Nocturne Acquisition Corporation Announces Closing of Fully-Exercised Over-Allotment Option in Connection with Its Initial Public Offering
-
Taysha Gene Therapies (TSHA) PT Raised to $67.50 at Chardan Capital Markets
-
Provention Bio Inc. (PRVB) PT Lowered to $22.50 at Chardan Capital Markets
-
Homology Medicines Inc. (FIXX) Promotes Tim Kelly to COO Position
-
Homology Medicines Announces Promotion of Tim Kelly to Chief Operating Officer
-
Form S-1/A Chardan NexTech Acquisit
-
MBP Announces Webinar on SPAC Investing 101: A Guide to Wall Street's Hottest Asset Class
-
Better Therapeutics to Become Publicly Traded via Merger with Mountain Crest Acquisition Corp. II (MCAD)
-
Better Therapeutics to Become Publicly Traded Prescription Digital Therapeutics Company via Merger with Mountain Crest Acquisition Corp. II
-
Achilles Therapeutics Announces Closing of $175.5 million Initial Public Offering
-
Dawson James Hires Veteran Analyst - James McIlree
-
Dawson James Hires Veteran Analyst - James McIlree
-
Nocturne Acquisition Corporation Announces Closing of $100 Million Initial Public Offering
-
Taysha Gene Therapies to Participate in Upcoming April Investor Healthcare Conferences
-
uniQure to Participate in Multiple Upcoming Industry Conferences in April
-
Form SC 13G Chardan Healthcare Acqui Filed by: Altium Capital Management LP
-
AgeX Therapeutics Reports Fourth Quarter and Annual 2020 Financial Results and Provides Business Update
-
Penny Stocks To Buy Now According To 3 Top Wall Street Analysts
-
IPO for Achilles Therapeutics plc (ACHL) Opens Flat, Drifts Lower
-
IPO for SPAC Nocturne Acquisition Corporation (MBTC) Opens at $10.01
-
Nocturne Acquisition Corporation Announces Pricing of $100 Million Initial Public Offering
-
Achilles Therapeutics plc (ACHL) Prices 9.75M Share IPO at $18/Sh
-
Sensorion Senior Management to Attend Four Conferences in April 2021
-
Achilles Therapeutics Announces Pricing of Initial Public Offering
-
Achilles Therapeutics Announces Pricing of Initial Public Offering
-
CohBar Reports Fourth Quarter 2020 Financial Results and Provides Business Update

